Mary Lynne Hedley Eli Lilly & CO (LLY) insider trading activity

Mary Lynne Hedley is Director of ELI LILLY & Co. Currently has a direct ownership of 1,878 shares of LLY, which is worth approximately $1.45 Million. The most recent transaction as insider was on Dec 16, 2024, when has been sold 12 shares (Common Stock) at a price of $779.0 per share, resulting in proceeds of $9,348. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.88K

22.19% 3M change

32.16% 12M change

Total Value Held $1.45 Million

Mary Lynne Hedley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2024	BUY Grant, award, or other acquisition	$9,348 $779.0 p/Share	12 Added 0.63%	1,878 Common Stock
Nov 18 2024	BUY Grant, award, or other acquisition	$229,068 $727.2 p/Share	315 Added 14.46%	1,864 Common Stock
Oct 21 2024	BUY Grant, award, or other acquisition	$9,967 $906.13 p/Share	11 Added 0.71%	1,548 Common Stock
Sep 16 2024	BUY Grant, award, or other acquisition	$10,158 $923.54 p/Share	11 Added 0.71%	1,537 Common Stock
Aug 19 2024	BUY Grant, award, or other acquisition	$10,139 $921.81 p/Share	11 Added 0.72%	1,524 Common Stock
Jul 15 2024	BUY Grant, award, or other acquisition	$9,504 $950.46 p/Share	10 Added 0.66%	1,513 Common Stock
Jun 17 2024	BUY Grant, award, or other acquisition	$9,735 $885.01 p/Share	11 Added 0.73%	1,503 Common Stock
May 20 2024	BUY Grant, award, or other acquisition	$10,181 $783.18 p/Share	13 Added 0.86%	1,490 Common Stock
Apr 15 2024	BUY Grant, award, or other acquisition	$9,760 $750.77 p/Share	13 Added 0.87%	1,477 Common Stock
Mar 18 2024	BUY Grant, award, or other acquisition	$9,914 $762.66 p/Share	13 Added 0.88%	1,464 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	$9,823 $755.66 p/Share	13 Added 0.89%	1,449 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	$10,153 $634.57 p/Share	16 Added 1.1%	1,437 Common Stock
Dec 18 2023	BUY Grant, award, or other acquisition	$9,855 $579.76 p/Share	17 Added 1.18%	1,421 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	$210,355 $597.6 p/Share	352 Added 20.06%	1,403 Common Stock
Oct 16 2023	BUY Grant, award, or other acquisition	$9,866 $616.64 p/Share	16 Added 1.5%	1,051 Common Stock
Sep 18 2023	BUY Grant, award, or other acquisition	$9,711 $571.28 p/Share	17 Added 1.62%	1,035 Common Stock
Aug 21 2023	BUY Grant, award, or other acquisition	$9,909 $550.5 p/Share	18 Added 1.74%	1,017 Common Stock
Jul 17 2023	BUY Grant, award, or other acquisition	$9,837 $447.14 p/Share	22 Added 2.15%	999 Common Stock
Jun 20 2023	BUY Grant, award, or other acquisition	$9,942 $451.95 p/Share	22 Added 2.2%	977 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	$9,993 $434.51 p/Share	23 Added 2.36%	953 Common Stock
Apr 17 2023	BUY Grant, award, or other acquisition	$10,053 $372.35 p/Share	27 Added 2.82%	930 Common Stock
Mar 20 2023	BUY Grant, award, or other acquisition	$10,008 $333.6 p/Share	30 Added 4.38%	655 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	$9,825 $327.51 p/Share	30 Added 4.59%	623 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	$10,016 $357.74 p/Share	28 Added 4.51%	593 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	$10,017 $357.78 p/Share	28 Added 4.72%	565 Common Stock

Also insider at

VEEV

VEEVA SYSTEMS INC Healthcare

Director

CNTA

Centessa Pharmaceuticals plc Healthcare

Director

MLH